Connie S Lebakken
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$5.7MFederal grants as PI13 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
13 awards · $5.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 13, 2024 | NIH | SBIR Phase I Development and Validation of a CNS Organoid Model of Temporal Lobe Epilepsy for Drug Discovery | $500K | STEM PHARM, INCORPORATED |
| Apr 23, 2024 | NIH | SBIR Phase I Human Neural Organoid Modeling of Alzheimer's Disease Neuroinflammation for Drug Discovery | $55K | STEM PHARM, INCORPORATED |
| Aug 21, 2023 | NIH | SBIR Phase I Human Neural Organoid Modeling of Alzheimer's Disease Neuroinflammation for Drug Discovery | $500K | STEM PHARM, INCORPORATED |
| Jul 11, 2023 | NIH | STTR Phase I Neural organoid models of the immunological microenvironment of glioblastoma for drug discovery applications | $407K | STEM PHARM, INCORPORATED |
| Feb 23, 2022 | NIH | SBIR Phase II Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications | $784K | STEM PHARM, INCORPORATED |
| Jul 28, 2021 | NIH | SBIR Phase II Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine | $679K | STEM PHARM, INCORPORATED |
| Mar 17, 2021 | NIH | SBIR Phase II Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications | $930K | STEM PHARM, INCORPORATED |
| Aug 12, 2020 | NIH | SBIR Phase II Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine | $868K | STEM PHARM, INCORPORATED |
| May 10, 2019 | NIH | SBIR Phase I Hydrogel-enabled self-assembled human brain organoids for developmental neurotoxicity applications | $225K | STEM PHARM, INCORPORATED |
| Feb 8, 2019 | NIH | SBIR Phase I Synthetic biomaterials designed for the generation of mouse neural organoids for in vitro toxicity screening. | $55K | STEM PHARM, INCORPORATED |
| Sep 5, 2018 | NIH | SBIR Phase I Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine | $225K | STEM PHARM, INCORPORATED |
| Aug 22, 2018 | NIH | SBIR Phase I Synthetic biomaterials designed for the generation and maintenance of mouse neural organoids for in vitro toxicity screening | $225K | STEM PHARM, INCORPORATED |
| Jan 19, 2017 | NIH | SBIR Phase I Biomaterials for mRNA-based cellular reprogramming | $291K | STEM PHARM, INCORPORATED |
Peer ranks
Federal funding#210
Awards as PI#72
Patents#273
Companies
- STEM PHARM, INCORPORATEDLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.